JP MORGAN/CALL/ABBOTT LABORATORIES/110/0.1/16.08.24 Share Price

Warrant

DE000JB8EU71

Market Closed - Bid/Ask 07:21:13 25/06/2024 pm IST After market 01:08:36 am
0.15 EUR 0.00% Intraday chart for JP MORGAN/CALL/ABBOTT LABORATORIES/110/0.1/16.08.24 0.135 -10.00%
Current month+36.36%
1 month-11.76%
Date Price Change
25/24/25 0.15 0.00%
24/24/24 0.15 -31.82%
21/24/21 0.22 +57.14%
20/24/20 0.14 -6.67%
19/24/19 0.15 +15.38%

Delayed Quote Börse Stuttgart

Last update June 25, 2024 at 07:21 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ABBOTT LABORATORIES
Issuer J.P. Morgan
WKN JB8EU7
ISINDE000JB8EU71
Date issued 18/12/2023
Strike 110 $
Maturity 16/08/2024 (51 Days)
Parity 10 : 1
Emission price 0.77
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 1.38
Lowest since issue 0.085
Spread 0.01
Spread %7.14%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
105.5 USD
Average target price
125.2 USD
Spread / Average Target
+18.64%
Consensus